Latest Breaking News On - Eyepoint pharmaceuticals daily - Page 3 : vimarsana.com

EyePoint Pharmaceuticals (NASDAQ:EYPT) PT Lowered to $38 00

EyePoint Pharmaceuticals (NASDAQ:EYPT) PT Lowered to $38 00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Robertw bairdTower research capitalEyepoint pharmaceuticals tradingEyepoint pharmaceuticals incAnalyst recommendations for eyepoint pharmaceuticalsJpmorgan chase coInstitutional trading of eyepoint pharmaceuticalsEyepoint pharmaceuticalsToth financial advisory corpNews ratings for eyepoint pharmaceuticals dailySherbrooke park advisersChina universal asset management coInvestment advisersGet free reportCapital one financialPoint pharmaceuticals

Mizuho Trims EyePoint Pharmaceuticals (NASDAQ:EYPT) Target Price to $30 00

Mizuho Trims EyePoint Pharmaceuticals (NASDAQ:EYPT) Target Price to $30 00
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Analyst recommendations for eyepoint pharmaceuticalsJpmorgan chase coEyepoint pharmaceuticals trading downEyepoint pharmaceuticalsEyepoint pharmaceuticals incFirst turn managementJennison associatesInsider transactions at eyepoint pharmaceuticalsHermes incNews ratings for eyepoint pharmaceuticals dailyFranklin resources incGet free reportCapital one financialPoint pharmaceuticals trading downPoint pharmaceuticalsCormorant asset management

EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Down to $19 74

Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) gapped down before the market opened on Monday . The stock had previously closed at $19.74, but opened at $13.89. EyePoint Pharmaceuticals shares last traded at $12.99, with a volume of 4,364,816 shares traded. Analyst Upgrades and Downgrades A number of equities research analysts have […]

Securities exchange commissionCapstone investment advisorsEyepoint pharmaceuticalsEyepoint pharmaceuticals price performanceEssex investment management coNews ratings for eyepoint pharmaceuticals dailyChina universal asset management coEyepoint pharmaceuticals incWoodstock corpJpmorgan chase coHedge funds weigh in on eyepoint pharmaceuticalsJanney montgomery scottGet free reportPoint pharmaceuticalsOne financialCormorant asset management

EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Up Following Insider Buying Activity

EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Up Following Insider Buying Activity
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Darioa paggiarinoFranklin resources incFirst turn managementNews ratings for eyepoint pharmaceuticals dailyEyepoint pharmaceuticalsSecurities exchange commissionJpmorgan chase coEyepoint pharmaceuticals incEyepoint pharmaceuticals stockInstitutional investors weigh in on eyepoint pharmaceuticalsHermes incJennison associatesGet free reportPoint pharmaceuticalsExchange commissionCormorant asset management

Cormorant Asset Management, Lp Acquires 581,765 Shares of EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) Stock

Cormorant Asset Management, Lp Acquires 581,765 Shares of EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

China universal asset management coSecurities exchange commissionQuarter for eyepoint pharmaceuticalsJpmorgan chase coEyepoint pharmaceuticals incNews ratings for eyepoint pharmaceuticals dailySherbrooke park advisersEyepoint pharmaceuticals price performanceTower research capitalEyepoint pharmaceuticalsInvestment advisersHedge funds weigh in on eyepoint pharmaceuticalsToth financial advisory corpGet free reportCormorant asset managementExchange commission